Back to UBS Group AG UBS Group AG

CORTCORT
Showing 8 of 30 quarters

Position history for UBS Group AGUBS Group AG's holdings in CORCEPT THERAPEUTICS INC

UBS Group AG holds 1.4M shares of CORT (CORCEPT THERAPEUTICS INC), worth $119.8M as of 2026-Q2. The position was increased (+1.0% shares). CORT represents 0.0% of UBS Group AG's portfolio.

Current Value

$119.8M

Current Shares

1.4M

Total Value Change

+$111.5M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.4M
+1.0%
$119.8M0.0%$86.95
30
2026-Q1
Increased
1.4M
+228.7%
$55M0.0%$40.31
47
2025-Q4
Decreased
414,851
-24.6%
$14.4M0.0%$34.80
0
2025-Q3
Increased
549,938
+413.8%
$45.7M0.0%$83.11
47
2025-Q2
Decreased
107,040
-71.3%
$7.9M0.0%$73.40
0
2025-Q1
Increased
372,653
+49.0%
$42.6M0.0%$114.22
40
2024-Q4
Increased
250,162
+40.4%
$12.6M0.0%$50.39
37
2024-Q3
Increased
178,196
+7.1%
$8.2M0.0%$46.28
29

Other major holders of CORT: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used